In July 2008, there was a media frenzy over the new drug "abiraterone" which a clinical study claimed dramatically reduced the size of a prostate tumor and had long term benefits that greatly outweighed any other treatment on the market. As prostate cancer is such a common and deadly disease amongst men it is little wonder there was such intense media coverage of this story.
However, at the time of writing the leading researcher for the team in Britain who are developing abiraterone has admitted that the press have hyped up the drug far beyond its actual capabilities at the present time. He also pointed out that the drug is not yet a cure, as it works on some people and not on others.
Alternative Cancer Treatments
Abiraterone is a prostate cancer new treatment that works along the same lines as hormone treatments. However, instead of blocking the testicles from generating testosterone the drug blocks the testosterone that is believed to be made by the tumor. This helps because it is now thought the tumor in its late stages actually lives off its own supply of testosterone.
It has been estimated that if the drug is a successful new treatment after a much larger clinical trial it will not be available until 2011.
The good news, even though it will be a small comfort to men who have prostate cancer now, is that the illness is finally getting the research it deserves and needs to find a prostate cancer new treatment. It is no longer the ignored disease that it once was, which gives us all hope that a cure will be found in the future.
Prostate Cancer New Treatment - There is Hope For Men With Advanced Prostate Cancer Alternative Cancer Treatments
No comments:
Post a Comment